Search Results

Palbociclib Isethionate 200 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Palbociclib Isethionate 100 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Telmisartan 100 mg  | 98.78%

TargetMol

Telmisartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of telmisartan is as an Angiotensin 2 Receptor Antagonist.

More Information Supplier Page

Telmisartan 50 mg  | 98.78%

TargetMol

Telmisartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of telmisartan is as an Angiotensin 2 Receptor Antagonist.

More Information Supplier Page

Forskolin 10 mg  | 98.83%

TargetMol

Forskolin, a potent activator of the adenylate cyclase (EC50: 0.5 μM), can increase the cAMP level. It is extracted from the plant Coleus forskohlii.

More Information Supplier Page

Dolasetron Mesylate hydrate 50 mg  | 99.86%

TargetMol

Dolasetron mesylate, a selective serotonin receptor antagonist, competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.

More Information Supplier Page

LDN193189 5 mg  | 99.11%

TargetMol

LDN193189 (DM 3189) is a selective BMP signaling inhibitor, inhibiting the transcriptional activity of ALK2 and ALK3 (IC50s: 0.8/0.8/5.3/16.7 nM for ALK1/2/3/6).

More Information Supplier Page

LDN193189 50 mg  | 99.11%

TargetMol

LDN193189 (DM 3189) is a selective BMP signaling inhibitor, inhibiting the transcriptional activity of ALK2 and ALK3 (IC50s: 0.8/0.8/5.3/16.7 nM for ALK1/2/3/6).

More Information Supplier Page